70 related articles for article (PubMed ID: 33054738)
1. Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p/OTUB2 axis.
Guo C; Zhang M; Jin X; Zhu C; Qian J; Tao M
Cell Biochem Funct; 2024 Jun; 42(4):e4020. PubMed ID: 38702967
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA LINC00885 upregulates NCK1 to promote cell viability and migration of triple-negative breast cancer cells through sponging miR-654-3p.
He P; Liu Z; Qi J; Shan J; Sheng J
Cancer Biomark; 2024; 39(1):63-78. PubMed ID: 37694355
[TBL] [Abstract][Full Text] [Related]
3. Long-chain noncoding RNA LINC01569 upregulates filamin A-interacting protein 1-like to prevent metastasis of triple-negative breast cancer via sponging miR-300.
Jiang X; Lin J; Zhu Z
Cancer Biomark; 2024; 39(2):79-94. PubMed ID: 37955081
[TBL] [Abstract][Full Text] [Related]
4. A novel long non-coding RNA MIR4500HG003 promotes tumor metastasis through miR-483-3p-MMP9 axis in triple-negative breast cancer.
Lin WD; Chang CH; Pan JK; Lin FC; Chen YC; Chen YJ; Wang PS; Hong WQ; Chen SY; Lin CH; Kuo YL; Chung WP; Cheng HC; Hsiao M; Yang CN; Lu PJ
Cell Death Dis; 2024 May; 15(5):310. PubMed ID: 38697967
[TBL] [Abstract][Full Text] [Related]
5. mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK.
Liu P; Ye F; Xie X; Li X; Tang H; Li S; Huang X; Song C; Wei W; Xie X
Oncotarget; 2016 Jun; 7(23):35188-98. PubMed ID: 27145268
[TBL] [Abstract][Full Text] [Related]
6. MiR-27a-3p Targeting GSK3β Promotes Triple-Negative Breast Cancer Proliferation and Migration Through Wnt/β-Catenin Pathway.
Wu R; Zhao B; Ren X; Wu S; Liu M; Wang Z; Liu W
Cancer Manag Res; 2020; 12():6241-6249. PubMed ID: 32801869
[TBL] [Abstract][Full Text] [Related]
7. miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells.
Li D; Hu J; Song H; Xu H; Wu C; Zhao B; Xie D; Wu T; Zhao J; Fang L
Am J Transl Res; 2017; 9(5):2276-2285. PubMed ID: 28559978
[TBL] [Abstract][Full Text] [Related]
8. Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression.
Chen SY; Zhang FL; Zhang YL; Liao L; Deng L; Shao ZM; Liu GY; Li DQ
Cancer Lett; 2024 Apr; 586():216672. PubMed ID: 38280476
[TBL] [Abstract][Full Text] [Related]
9. YAP1-induced RBM24 promotes the tumorigenesis of triple-negative breast cancer through the β-catenin pathway.
Chen X; Lin X; Xia X; Xiang X
J Investig Med; 2024 Jun; 72(5):403-413. PubMed ID: 38441112
[TBL] [Abstract][Full Text] [Related]
10. H3K27ac-induced RHOXF2 activates Wnt2/β-catenin pathway by binding to HOXC13 to aggravate the malignant progression of triple negative breast cancer.
Guo M; Wang R; Nie M; Zhang H; Wang C; Song C; Niu S
Cell Signal; 2024 Apr; 120():111196. PubMed ID: 38697448
[TBL] [Abstract][Full Text] [Related]
11. miRNA-200c-3p deficiency promotes epithelial-mesenchymal transition in triple-negative breast cancer by activating CRKL expression.
Nie F; Zhang Q; Ma W; Yan J
Discov Oncol; 2024 May; 15(1):146. PubMed ID: 38717531
[TBL] [Abstract][Full Text] [Related]
12. WTAP Mediates NUPR1 Regulation of LCN2 Through m
Tan M; He Y; Yi J; Chen J; Guo Q; Liao N; Peng L
Biochem Genet; 2024 Apr; 62(2):876-891. PubMed ID: 37477758
[TBL] [Abstract][Full Text] [Related]
13. miR-27-3p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to the Antitumor Agent Olaparib by Targeting PSEN-1, the Catalytic Subunit of Γ-Secretase.
Zhao M; Sun B; Wang Y; Qu G; Yang H; Wang P
Front Oncol; 2021; 11():694491. PubMed ID: 34169001
[TBL] [Abstract][Full Text] [Related]
14. Applications of RNA Indexes for Precision Oncology in Breast Cancer.
Ma L; Liang Z; Zhou H; Qu L
Genomics Proteomics Bioinformatics; 2018 Apr; 16(2):108-119. PubMed ID: 29753129
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-Specific Protease 6 n-Terminal-like Protein (USP6NL) and the Epidermal Growth Factor Receptor (EGFR) Signaling Axis Regulates Ubiquitin-Mediated DNA Repair and Temozolomide-Resistance in Glioblastoma.
Su IC; Su YK; Chuang HY; Yadav VK; Setiawan SA; Fong IH; Yeh CT; Huang HC; Lin CM
Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884836
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs miR-142-5p, miR-150-5p, miR-320a-3p, and miR-4433b-5p in Serum and Tissue: Potential Biomarkers in Sporadic Breast Cancer.
Carvalho TM; Brasil GO; Jucoski TS; Adamoski D; de Lima RS; Spautz CC; Anselmi KF; Ozawa PMM; Cavalli IJ; Carvalho de Oliveira J; Gradia DF; Ribeiro EMSF
Front Genet; 2022; 13():865472. PubMed ID: 35846122
[TBL] [Abstract][Full Text] [Related]
17. The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis.
Duan Y; Chen HL; Ling M; Zhang S; Ma FX; Zhang HC; Lv XA
Mol Cell Biol; 2022 Jan; 42(1):e0016321. PubMed ID: 34780286
[TBL] [Abstract][Full Text] [Related]
18. Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer.
Mediratta K; El-Sahli S; D'Costa V; Wang L
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33256070
[TBL] [Abstract][Full Text] [Related]
19. USP6NL mediated by LINC00689/miR-142-3p promotes the development of triple-negative breast cancer.
Ma T; Liu H; Liu Y; Liu T; Wang H; Qiao F; Song L; Zhang L
BMC Cancer; 2020 Oct; 20(1):998. PubMed ID: 33054738
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
